Submit Deal

PAPPAS CAPITAL

HQ - Durham

Summary

Pappas Capital operates as a venture capital firm. The Company invests in biotechnology, pharmaceuticals, drug delivery, diagnostics, medical devices, and related companies. Pappas Capital serves clients in the United States.

Deals Overview

Total Deals6

Valued Deals6

Total Value£ 2.42 B

Avg. Deal Size£ 403 M

Market Context

Subsidiaries

VELOSBIO INC

2 transactions

Senior Management

Tom Mathers
CEO
Matthew Boyer
CFO
Kyle Rasbach
Managing Partner

Sort

08 Jul 2020|United States|Biotechnology

Target: VELOSBIO INC

Bidder: CORMORANT ASSET MANAGEMENT

14 Service Providers

2 Target | 12 Bidder

16 Dealmakers

2 Target | 14 Bidder

£ 105 M

Value

17 Jul 2020|United States|Pharmaceuticals

Target: BIOATLA

Bidder: SOLEUS CAPITAL

10 Service Providers

2 Target | 8 Bidder

14 Dealmakers

6 Target | 8 Bidder

£ 55 M

Value

05 Nov 2020|United States|Biotechnology

Target: VELOSBIO INC

Bidder: MERCK & CO

17 Service Providers

4 Target | 4 Bidder | 9 Vendor

55 Dealmakers

20 Target | 9 Bidder | 26 Vendor

£ 2.12 B

Value

02 Jun 2022|United States|Biotechnology

Target: NUPROBE

Bidder: ASTRAZENECA PLC

9 Service Providers

3 Target | 6 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 39 M

Value

20 Jun 2023|United States|Biotechnology

Target: VERALOX THERAPEUTICS

Bidder: PAPPAS CAPITAL

3 Service Providers

2 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 18 M

Value

30 Apr 2024|United States|Biotechnology

Target: ENLAZA THERAPEUTICS

Bidder: AVALON VENTURES INC

4 Service Providers

3 Target | 1 Bidder

3 Dealmakers

2 Target | 1 Bidder

£ 79 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy